webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-SMP

  CAS No.: 55750-61-3   Cat No.: BADC-00366   Purity: 95% 4.5  

N-SMP is a potent synthetic compound known for its efficacy against various neurological disorders. As a powerful inhibitor, this compound specifically targets key enzymes involved in the progression of these debilitating diseases. In addition, N-SMP is also widely used as a linker for antibody-drug conjugation.

N-SMP

Structure of 55750-61-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C10H8N2O6
Molecular Weight
252.18
Shipping
Room temperature, or blue ice upon request.
Shipping
-20 °C under inert atmosphere

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
5 g $698 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
1-[2-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl]-1H-pyrrole-2,5-dione; N-(α-Maleimidoacetoxy)succimide; AMAS; N-Succinimidyl maleimidoacetate; Maleimidoacetic Acid N-Succinimidyl Ester; N-(alpha-Maleimidoacetoxy)succinimide; a-Maleimidoacetic acid-NHS
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 2-(2,5-dioxopyrrol-1-yl)acetate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CN2C(=O)C=CC2=O
InChI
InChI=1S/C10H8N2O6/c13-6-1-2-7(14)11(6)5-10(17)18-12-8(15)3-4-9(12)16/h1-2H,3-5H2
InChIKey
TYKASZBHFXBROF-UHFFFAOYSA-N
Density
1.630±0.10 g/cm3 (Predicted)
Solubility
Slightly soluble in chloroform, methanol
Melting Point
174-175 °C
Flash Point
213.9±29.3 °C
Index Of Refraction
1.620
PSA
101.06000
Vapor Pressure
0.0±1.0 mmHg at 25°C
Appearance
Light Yellow to white Solid
Shipping
Room temperature, or blue ice upon request.
Storage
-20 °C under inert atmosphere
Pictograms
Irritant
Signal Word
Warning
Boiling Point
430.1±47.0 °C (Predicted)
1.Selective elimination of the free fatty acid fraction from esterified fatty acids in rat plasma through chemical derivatization and immobilization on amino functionalized silica nano-particles.
Chen J1, Lyu Q2, Yang M3, Chen Z2, He J4. J Chromatogr A. 2016 Jan 29;1431:197-204. doi: 10.1016/j.chroma.2015.12.078. Epub 2015 Dec 31.
A high throughput and low cost approach to separate free fatty acids (FFAs) from phospholipid and acylglycerols (esterified fatty acids, EFAs) has been demonstrated, which may be widely used as a sample preparation method in the metabolomics and lipid research. The optimal conditions for FFAs reacting with N-hydroxysuccinimide (NHS) only need 10min at room temperature to obtain a 93.5% yield of FFAs-NHS ester. The rest 6% FFA transformed into N-cyclohexyl-fatty acid-amide which is stable to methyl esterification adopted for fatty acids analysis. 10min are taken for FFAs-NHS ester to react with amino functionalized silica nanoparticles to immobilize the FFAs. The separation of FFAs from EFAs could be carried out readily by centrifugation. The whole process including derivatization, immobilization, and centrifugation takes less than 40min. Much more accurate fatty acids composition of rat plasma EFAs could be obtained by this approach than the previous reported methods.
2.Mitsunobu alkylation of cancerostatic 5-fluorouridine with (2E)-10-hydroxydec-2-enoic acid, a fatty acid from royal jelly with multiple biological activities.
Ottenhaus V1, Rosemeyer H2. Chem Biodivers. 2015 Sep;12(9):1307-12. doi: 10.1002/cbdv.201500048.
5-Fluorouridine (1) - a nucleoside antimetabolite with strong cancerostatic properties - was protected i) at the 2'- and 3'-OH groups with a heptan-4-ylidene residue and ii) at the 5'-OH group with a (4-methoxyphenyl)(diphenyl)methyl residue. This fully protected compound, 3, was submitted to a Mitsunobu reaction with the N-hydroxysuccinimide (NHS) ester, 5, of (2E)-10-hydroxydec-2-enoic acid (4) which gave nucleolipid 6. The latter was detritylated with Cl2 CHCOOH to yield the co-drug 7 as NHS ester.
3.Biocatalytic synthesis of starch esters by immobilized lipase on magnetic microparticles.
Prasertpornsakun N1, Raita M1, Laosiripojana N1, Champreda V2. Biosci Biotechnol Biochem. 2015;79(11):1750-8. doi: 10.1080/09168451.2015.1056507. Epub 2015 Jun 24.
Enzymatic esterification is an efficient approach for modifying starch to functionalized biomaterials. In this study, conversion of cassava starch to fatty acid acyl esters using immobilized Thermomyces lanuginosus lipase on Fe3O4 microparticles modified with 3-aminopropyltriethoxysilane and covalently linked by 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide and N-hydroxysuccinimide (Fe3O4-AP-ED-lipase) in a solvent-free system was studied. An optimized reaction containing 5% w/v gelatinized starch, 1% v/v Triton X-100, and 1% w/v biocatalyst with 2.5% w/v of fatty acids (palmitic, oleic, or linoleic acid) resulted in esterified products with a degree of substitution (DS) of 0.12-0.14, while a slightly lower DS was observed using crude palm fatty acid distillate as the acyl donor with 42.9-59.6% recovery yield. Increasing DS led to lower glass transition temperature and higher viscosity of the esterified products. The enzyme showed high operational stability with 85% retaining in activity after recycling in three consecutive batches with simple separation by magnetization, leading to improved process economics.
4.Controllable layer-by-layer assembly of PVA and phenylboronic acid-derivatized chitosan.
Zhang D1, Yu G2, Long Z2, Yang G3, Wang B4. Carbohydr Polym. 2016 Apr 20;140:228-32. doi: 10.1016/j.carbpol.2015.12.032. Epub 2015 Dec 17.
Phenylboronic acid-derivatized chitosan (chitosan-PBA) were prepared by grafting small molecules bearing phenylboronic acid groups onto chitosan with N-hydroxysuccinimide (NHS) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) as a coupling reagent pair. Self-assembly multilayer thin films of chitosan-PBA and poly(vinyl alcohol) were subsequently produced under pH control on supporting surfaces, either a silicon wafer or polystyrene latex particles. The driving force of the self-assembly was the ester formation of phenylboronic acid containing polymers with PVA, which can be "turned off" by simple pH control.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: DBCO-PEG4-Val-Cit-PAB-MMAF | Fmoc-N-amido-PEG2-acetic acid | N-(2-(3-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | Py-MPB-amino-C3-PBD | MAC glucuronide linker-2 | Pyrrolobenzodiazepine (PBD) | Mal-PEG4-VA-PBD | VA-PAB-PBD | MC-VC-PAB-Tubulysin M | N-SMP
Send Inquiry
Verification code
Inquiry Basket